Sivafl mice have loxP sites flanking exons 1-4 of the SIVA1, apoptosis-inducing factor (Siva1) gene. This strain may be useful for studying the pro-apoptotic roles of Siva, and its potential as a cancer therapy target.
Laura Attardi, Stanford University Medical Center
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Conditional ready (e.g. floxed), No functional change) | Siva1 | SIVA1, apoptosis-inducing factor |
Sivafl mice have loxP sites flanking exons 1-4 of the SIVA1, apoptosis-inducing factor (Siva1) gene. Siva is a pro-apoptotic protein through its ability to induce CD27-mediated apoptosis. It is also a direct target for p53, a critical tumor suppressor. Siva has also been shown to play a role in promoting proliferation and tumorigenesis in a p53-independent manner by stimulating mTOR signaling and metabolism. Mice that are homozygous for this allele are viable and fertile. When these mutant mice are bred to mice that express Cre recombinase, resulting offspring will have exons 1-4 deleted in cre-expressing tissues. If Siva is deleted in the whole-body during development, mice are embryonic lethal.
For example, when crossed to B6.129S4-Krastm4Tyj/J mice (Stock No. 008179), which have an upstream floxed transcriptional stop cassette blocking expression of an oncogenic KrasG12D protein, and compound mutant mice are infected with Ad-Cre to drive expression of KrasG12D and excision of the Siva locus in the lung, resulting mice have fewer adenomas and adenocarcinomas, and reduced tumor burden. In this model, Siva inactivation inhibits non–small cell lung cancer (NSCLC) development.
A targeting vector was designed to insert a single loxP upstream of exon 1, and a loxP-flanked puromycin resistance (puro) cassette site downstream of exon 4 of the SIVA1, apoptosis-inducing factor (Siva1) gene. The construct was electroporated into 129S4/SvJae-derived J1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts and resulting chimeric males were bred with C57BL/6J females. Offspring were bred to CMV-cre mice on a 129Sv;C57BL/6J background to delete the puro cassette. Resulting mice contained multiple gene rearrangments; intact floxed-exons 1-4, intact floxed-puro cassette, or excision of exons 1-4 and the puro cassette. Progeny containing only the floxed-exons 1-4 were bred with 129Sv;C57BL/6J mice and the resulting colony of Sivafl mice were maintained on a mixed background. Upon arrival, mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony.
Allele Name | targeted mutation 1.1, Laura D Attardi |
---|---|
Allele Type | Targeted (Conditional ready (e.g. floxed), No functional change) |
Allele Synonym(s) | Sivafl |
Gene Symbol and Name | Siva1, SIVA1, apoptosis-inducing factor |
Gene Synonym(s) | |
Strain of Origin | 129S4/SvJae |
Chromosome | 12 |
Molecular Note | A targeting vector is designed to insert a single loxP upstream of exon 1, and a loxP-flanked puromycin resistance (puro) cassette site downstream of exon 4 of the SIVA1, apoptosis-inducing factor (Siva1) gene. Cre-mediated recombination removed the floxed puro cassette leaving exons 1-4 floxed. |
When maintaining a live colony mice homozygous for the floxed allele may be bred together.
When using the Sivafl mouse strain in a publication, please cite the originating article(s) and include JAX stock #027800 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Siva1<tm1.1Att> |
Frozen Mouse Embryo | STOCK Siva1<tm1.1Att>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Siva1<tm1.1Att>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Siva1<tm1.1Att>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | STOCK Siva1<tm1.1Att>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.